| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology (Drs. Tan, Khajavi, Nagamitsu, Jankovic, and Ashizawa), Baylor College of Medicine, Veterans Affairs Medical Center (Drs. Khajavi, Thornby, Nagamitsu, and Ashizawa), Houston, Texas.
Address correspondence and reprint requests to Dr. Tetsuo Ashizawa, Department of Neurology, Baylor College of Medicine, 6550 Fannin, Smith 1801, Houston, TX 77030; e-mail: tetsuoa{at}bcm.tmc.edu
BACKGROUND: In recent years, interest in gene–environment interactions has spurred a great number of association studies on polymorphism of different genes.
OBJECTIVE: To review case-control studies of genetic polymorphisms in PD, and perform meta-analysis of individual gene polymorphism.
METHODS: The authors searched the Medline database (PubMed) for publications (English language) from January 1966 to November 1999 for association studies in PD. The key words used were "PD" and "polymorphism." The authors supplemented the search with relevant references quoted in these published articles. Those with four or more independent studies of a specific gene polymorphism were subjected to meta-analysis, with the exception of cytochrome-P450 enzyme polymorphisms, for which meta-analyses results were already available in the literature.
RESULTS: The authors identified 84 studies on 14 genes, including dopamine receptors (DRD2 and DRD4), dopamine transporter (DAT), monoamine oxidase (MAOA and MAOB), catechol-O-methyltransferase (COMT), N-acetyltransferase 2 (NAT2), APOE, glutathione transferase (GSTT1, GSTM1, GSTP1, and GSTZ1), and mitochondrial genes (tRNAGlu and ND2). Four polymorphisms showed significant association with PD: slow acetylator genotypes of NAT2 (PD:control OR = 1.36), allele >188bp of the MAOB (GT)n polymorphism (OR = 2.58), the deletion allele of GSTT1 (OR = 1.34), and A4336G of tRNAGlu (OR = 3.0). No significant differences were found for the other genes.
CONCLUSION: Significant associations with PD were found in polymorphisms of NAT2, MAOB, GSTT1, and tRNAGlu. Although significant association does not imply a causal relationship between the presence of the polymorphisms and PD pathogenesis, their pathophysiologic significance should be studied further.
This article has been cited by other articles:
|
|
 |
|
  F D Dick, G De Palma, A Ahmadi, A Osborne, N W Scott, G J Prescott, J Bennett, S Semple, S Dick, P Mozzoni, et al. Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study Occup. Environ. Med., October 1, 2007; 64(10): 673 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E.-K. Tan and J. Jankovic Genetic testing in Parkinson disease: promises and pitfalls. Arch Neurol, September 1, 2006; 63(9): 1232 - 1237. [Full Text] [PDF]
|
|
|
|
|
|
M. M. K. Muqit, S. Gandhi, and N. W. Wood Mitochondria in Parkinson disease: back in fashion with a little help from genetics. Arch Neurol, May 1, 2006; 63(5): 649 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Andrews, T Ressiniotis, D M Turnbull, M Birch, S Keers, P F Chinnery, and P G Griffiths The role of mitochondrial haplogroups in primary open angle glaucoma. Br J Ophthalmol, April 1, 2006; 90(4): 488 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cao, C. C. Gelwix, K. A. Caldwell, and G. A. Caldwell Torsin-Mediated Protection from Cellular Stress in the Dopaminergic Neurons of Caenorhabditis elegans J. Neurosci., April 13, 2005; 25(15): 3801 - 3812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.-K. Tan, D. K.-Y. Chan, P.-W. Ng, J. Woo, Y. Y. Teo, K. Tang, L.-P. Wong, S. S. Chong, C. Tan, H. Shen, et al. Effect of MDR1 Haplotype on Risk of Parkinson Disease Arch Neurol, March 1, 2005; 62(3): 460 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Huang, P. C. Chen, and C. Poole APOE-{epsilon}2 allele associated with higher prevalence of sporadic Parkinson disease Neurology, June 22, 2004; 62(12): 2198 - 2202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Jiang, T. Ellis, and A. R. Greenlee Genotyping Parkinson Disease-Associated Mitochondrial Polymorphisms Clin. Med. Res., May 1, 2004; 2(2): 99 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C G L Lee, K Tang, Y B Cheung, L P Wong, C Tan, H Shen, Y Zhao, R Pavanni, E J D Lee, M-C Wong, et al. MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic Chinese J. Med. Genet., May 1, 2004; 41(5): e60 - e60. [Full Text] [PDF]
|
|
|
|
|
|
E. K. Tan, A. Chai, Y. Y. Teo, Y. Zhao, C. Tan, H. Shen, V. R. Chandran, M. L. Teoh, Y. Yih, R. Pavanni, et al. Alpha-synuclein haplotypes implicated in risk of Parkinson's disease Neurology, January 13, 2004; 62(1): 128 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sedelis, K. Hofele, R. K. W. Schwarting, J. P. Huston, and J. K. Belknap Chromosomal Loci Influencing the Susceptibility to the Parkinsonian Neurotoxin 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine J. Neurosci., September 10, 2003; 23(23): 8247 - 8253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. J. Dekker, V. Bonifati, and C. M. van Duijn Parkinson's disease: piecing together a genetic jigsaw Brain, August 1, 2003; 126(8): 1722 - 1733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Siderowf and M. Stern Update on Parkinson Disease Ann Intern Med, April 15, 2003; 138(8): 651 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. van der Walt, E.R. Martin, W. K. Scott, F. Zhang, M.A. Nance, R. L. Watts, J. P. Hubble, J. L. Haines, W. C. Koller, K. Lyons, et al. Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease Neurology, April 8, 2003; 60(7): 1189 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.K.Y. Chan, M.K.P. Lam, R. Wong, W.T. Hung, and D.E.L. Wilcken Strong association between N-acetyltransferase 2 genotype and PD in Hong Kong Chinese Neurology, March 25, 2003; 60(6): 1002 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Levecque, A. Elbaz, J. Clavel, F. Richard, J.-S. Vidal, P. Amouyel, C. Tzourio, A. Alperovitch, and M.-C. Chartier-Harlin Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study Hum. Mol. Genet., January 1, 2003; 12(1): 79 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.K. Tan, A. Chai, Y. Zhao, S.Y. Lum, S.M.C. Fook-Chong, M.L. Teoh, Y. Yih, R. Pavanni, and M.C. Wong Mitochondrial complex I polymorphism and cigarette smoking in Parkinson's disease Neurology, October 22, 2002; 59(8): 1288 - 1289. [Full Text] [PDF]
|
|
|
|
 |
|
 T Foltynie, S Sawcer, C Brayne, and R A Barker The genetic basis of Parkinson's disease J. Neurol. Neurosurg. Psychiatry, October 1, 2002; 73(4): 363 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Simon, M. Lin, and A Pascual-Leone "Nature versus nurture" and incompletely penetrant mutations J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(6): 686 - 689. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Hernan, H. Checkoway, R. O'Brien, P. Costa-Mallen, I. De Vivo, G. A. Colditz, D. J. Hunter, K. T. Kelsey, and A. Ascherio MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD Neurology, May 14, 2002; 58(9): 1381 - 1387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-Y. Xu, R. Liang, J. Jankovic, C. Hunter, Y.-X. Zeng, T. Ashizawa, D. Lai, and W.-D. Le Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease Neurology, March 26, 2002; 58(6): 881 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. E. Maher, L. I. Golbe, A. M. Lazzarini, M. H. Mark, L. J. Currie, G. F. Wooten, M. Saint-Hilaire, J. B. Wilk, J. Volcjak, J. E. Maher, et al. Epidemiologic study of 203 sibling pairs with Parkinson's disease: The GenePD study Neurology, January 8, 2002; 58(1): 79 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Martin, W. K. Scott, M. A. Nance, R. L. Watts, J. P. Hubble, W. C. Koller, K. Lyons, R. Pahwa, M. B. Stern, A. Colcher, et al. Association of Single-Nucleotide Polymorphisms of the Tau Gene With Late-Onset Parkinson Disease JAMA, November 14, 2001; 286(18): 2245 - 2250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. DeStefano, L. I. Golbe, M. H. Mark, A. M. Lazzarini, N. E. Maher, M. Saint-Hilaire, R. G. Feldman, M. Guttman, R. L. Watts, O. Suchowersky, et al. Genome-wide scan for Parkinson's disease: The Gene PD Study Neurology, September 25, 2001; 57(6): 1124 - 1126. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
